{
  "doc_id": "a98dd4fe258c7fd81b667424ee32d2074868becdf3221a95d8de821a93ac441e",
  "chunk_entities": [
    {
      "chunk_id": "7ae73eca45d3ecf465f08a11c0b9b0ba",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "obesity-induced increases"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory",
          "context": "inflammatory cytokines"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behaviors",
          "context": "increased anxiety-like behaviors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Obesity",
          "context": "Obesity was studied"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory",
          "context": "inflammatory pathways"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ibuprofen",
          "context": "oral ibuprofen"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "TNF-\u03b1 blocker"
        },
        {
          "entity_type": "Compound",
          "entity_name": "etanercept",
          "context": "TNF-\u03b1 blocker etanercept"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obese",
          "context": "obese male mice"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behaviors",
          "context": "elevated anxiety-like behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "pro-inflammatory cytokines"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Anti-inflammatory",
          "context": "Anti-inflammatory treatments"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ibuprofen",
          "context": "oral ibuprofen"
        },
        {
          "entity_type": "Effect",
          "entity_name": "ameliorated anxiety-like behaviors",
          "context": "ameliorated anxiety-like behaviors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ibuprofen",
          "context": "ibuprofen and CFR treatments"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "hippocampal TNF-\u03b1 expression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory",
          "context": "pro-inflammatory cytokines"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "increased TNF-\u03b1 in the brain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behaviors",
          "context": "increases in anxiety-like behaviors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obese",
          "context": "obese mice"
        }
      ]
    },
    {
      "chunk_id": "264103cd0e118324d664c2771c8af695",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "The role of TNF-\u03b1 in modulating anxiety"
        },
        {
          "entity_type": "Compound",
          "entity_name": "etanercept",
          "context": "the TNF-\u03b1 blocker etanercept into the brain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "modulating anxiety",
          "context": "in modulating anxiety was subsequently determined"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behaviors",
          "context": "impact on anxiety-like behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic transmission",
          "context": "synaptic transmission in the ventral hippocampus"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "modulating anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety-like behaviors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Etanercept",
          "context": "Etanercept selectively reduced anxiety-like behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced anxiety-like behaviors",
          "context": "Etanercept selectively reduced anxiety-like behaviors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obese",
          "context": "in obese db/db mice"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-related behaviors",
          "context": "increases in anxiety-related behaviors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "dependent on TNF-\u03b1 signaling"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety-related behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic transmission",
          "context": "Changes in synaptic transmission in the hippocampus"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety behaviors",
          "context": "underlie anxiety behaviors in obese mice"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "anxiety behaviors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obese",
          "context": "in obese mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "TNF-\u03b1 inhibition diminished the frequency"
        },
        {
          "entity_type": "Effect",
          "entity_name": "TNF-\u03b1 inhibition",
          "context": "TNF-\u03b1 inhibition diminished the frequency"
        },
        {
          "entity_type": "Effect",
          "entity_name": "diminished the frequency and amplitude of excitatory postsynaptic currents",
          "context": "diminished the frequency and amplitude of excitatory postsynaptic currents"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mood regulation",
          "context": "associated with mood regulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Etanercept",
          "context": "Etanercept injections are currently used clinically"
        },
        {
          "entity_type": "Effect",
          "entity_name": "chronic inflammation",
          "context": "conditions of chronic inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic inflammation",
          "context": "conditions of chronic inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "rheumatoid arthritis",
          "context": "including rheumatoid arthritis"
        },
        {
          "entity_type": "Disease",
          "entity_name": "psoriasis",
          "context": "and psoriasis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "this TNF-\u03b1 blocker could be a promising therapeutic candidate"
        },
        {
          "entity_type": "Effect",
          "entity_name": "therapeutic",
          "context": "a promising therapeutic candidate"
        },
        {
          "entity_type": "Effect",
          "entity_name": "treating anxiety",
          "context": "for treating anxiety in obese individuals"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "treating anxiety in obese individuals"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obese",
          "context": "in obese individuals"
        }
      ]
    },
    {
      "chunk_id": "e8379c632ac217cc2a7d179199c87dfd",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "obesity rates are higher"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "suffer from anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "lead to the anxiety bias"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "in the context of obesity"
        }
      ]
    },
    {
      "chunk_id": "daf16cd30d7c3df2711e042eff9dfb9c",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "prevalence of obesity in humans"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "42.8%",
          "context": "adults is 42.8%"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "20.6%",
          "context": "that, 20.6%"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroinflammatory responses",
          "context": "modulates neuroinflammatory responses"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-alpha",
          "context": "efficacy of a TNF-alpha blocker"
        },
        {
          "entity_type": "Compound",
          "entity_name": "etanercept",
          "context": "blocker like etanercept"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reducing anxiety-like behaviors",
          "context": "in reducing anxiety-like behaviors"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety-like behaviors",
          "context": "reducing anxiety-like behaviors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-alpha",
          "context": "by which TNF-alpha targets"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety disorders",
          "context": "treating anxiety disorders"
        }
      ]
    },
    {
      "chunk_id": "93c611d3eb33ef56d0c2d276ae38bb64",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "mood disorders",
          "context": "may cause mood disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "treatment resistance",
          "context": "high rate of treatment resistance"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "contributing to anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depressive disorders",
          "context": "and depressive disorders"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNF-\u03b1",
          "context": "role for TNF-\u03b1 in obesity-associated anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obesity-associated anxiety",
          "context": "in obesity-associated anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "in the context of obesity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety disorders",
          "context": "targeting anxiety disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "neuroimmune activation",
          "context": "lead to neuroimmune activation"
        }
      ]
    },
    {
      "chunk_id": "e612f901668b135c2773a53bb22af559",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "tumor necrosis factor-alpha",
          "context": "Brain tumor necrosis factor-alpha mediates"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behavior",
          "context": "mediates anxiety-like behavior"
        }
      ]
    },
    {
      "chunk_id": "5ad7b4d387e61e0bd23bf89b2b87f14b",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "The impact of obesity and hypercaloric diet consumption on anxiety"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "on anxiety and emotional behavior across the lifespan"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emotional behavior",
          "context": "on anxiety and emotional behavior across the lifespan"
        },
        {
          "entity_type": "Disease",
          "entity_name": "adiposity",
          "context": "Relationship between adiposity, emotional status and eating behaviour"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emotional status",
          "context": "adiposity, emotional status and eating behaviour in obese women"
        },
        {
          "entity_type": "Effect",
          "entity_name": "eating behaviour",
          "context": "emotional status and eating behaviour in obese women"
        },
        {
          "entity_type": "Disease",
          "entity_name": "inflammation",
          "context": "role of inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "inflammation",
          "context": "From inflammation to sickness and depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "sickness",
          "context": "From inflammation to sickness and depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "to sickness and depression: when the immune system subjugates the brain"
        },
        {
          "entity_type": "Disease",
          "entity_name": "anxiety",
          "context": "Sex differences in anxiety and emotional behavior"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emotional behavior",
          "context": "Sex differences in anxiety and emotional behavior"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tumor necrosis factor-alpha",
          "context": "Brain tumor necrosis factor-\u03b1 mediates anxiety-like behavior"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety-like behavior",
          "context": "Brain tumor necrosis factor-\u03b1 mediates anxiety-like behavior"
        },
        {
          "entity_type": "Disease",
          "entity_name": "severe obesity",
          "context": "in a mouse model of severe obesity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obesity",
          "context": "Prevalence of obesity among adults and youth"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tumor necrosis factor-alpha",
          "context": "Adipose expression of tumor necrosis factor-\u03b1: direct role"
        },
        {
          "entity_type": "Disease",
          "entity_name": "obesity-linked insulin resistance",
          "context": "in obesity-linked insulin resistance"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tumor necrosis factor antagonist",
          "context": "A randomized controlled trial of the tumor necrosis factor antagonist infliximab"
        },
        {
          "entity_type": "Compound",
          "entity_name": "infliximab",
          "context": "the tumor necrosis factor antagonist infliximab for treatment-resistant depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "treatment-resistant depression",
          "context": "infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inflammatory",
          "context": "the role of baseline inflammatory biomarkers"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Obesity",
          "context": "Obesity is associated with hypothalamic injury in rodents and humans"
        },
        {
          "entity_type": "Disease",
          "entity_name": "hypothalamic injury",
          "context": "associated with hypothalamic injury in rodents and humans"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Obesity",
          "context": "Obesity is associated with macrophage accumulation in adipose tissue"
        }
      ]
    }
  ],
  "total_entities": 101,
  "extraction_date": "2026-02-01T08:53:14.539633+00:00"
}